Liu K - Search Results

1

Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma.

Li ZL, Han J, Liu K, Xing H, Wu H, Lau WY, Pawlik TM, Li C, Wang MD, Yu JJ, Wu MC, Shen F, Yang T. Li ZL, et al. Among authors: liu k. Hepatobiliary Surg Nutr. 2019 Apr;8(2):88-100. doi: 10.21037/hbsn.2018.11.20. Hepatobiliary Surg Nutr. 2019. PMID: 31098356 Free PMC article.

2

Primary hepatic malignant fibrous histiocytoma mimicking cystadenocarcinoma: a case report.

Ding GH, Wu MC, Yang JH, Cheng SQ, Li N, Liu K, Dai BH, Cong WM. Ding GH, et al. Among authors: liu k. Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):620-3. Hepatobiliary Pancreat Dis Int. 2006. PMID: 17085355

3

Correlation between the survival rate of the patients with synchronous hepatic metastases from gastric carcinoma after surgical resection and patient's index.

Yang XW, Li Z, Liu K, Fu XH, Yang JH, Wu MC. Yang XW, et al. Among authors: liu k. Chin Med J (Engl). 2012 Mar;125(5):747-51. Chin Med J (Engl). 2012. PMID: 22490567

4

Human sulfatase-1 inhibits the migration and proliferation of SMMC-7721 hepatocellular carcinoma cells by downregulating the growth factor signaling.

Liu H, Fu X, Ji W, Liu K, Bao L, Yan Y, Wu M, Yang J, Su C. Liu H, et al. Among authors: liu k. Hepatol Res. 2013 May;43(5):516-25. doi: 10.1111/j.1872-034X.2012.01080.x. Epub 2012 Aug 20. Hepatol Res. 2013. PMID: 22900980

5

Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.

Yang T, Hu LY, Li ZL, Liu K, Wu H, Xing H, Lau WY, Pawlik TM, Zeng YY, Zhou YH, Gu WM, Wang H, Chen TH, Han J, Li C, Wang MD, Wu MC, Shen F. Yang T, et al. Among authors: liu k. J Gastrointest Surg. 2020 Feb;24(2):320-329. doi: 10.1007/s11605-018-04071-2. Epub 2019 Jan 7. J Gastrointest Surg. 2020. PMID: 30617773

6

Precancer antiviral treatment reduces microvascular invasion of early-stage Hepatitis B-related hepatocellular carcinoma.

Liu K, Duan J, Liu H, Yang X, Yang J, Wu M, Chang Y. Liu K, et al. Among authors: liu h. Sci Rep. 2019 Feb 18;9(1):2220. doi: 10.1038/s41598-019-39440-7. Sci Rep. 2019. PMID: 30778112 Free PMC article.

7

Publisher Correction: Precancer antiviral treatment reduces microvascular invasion of early-stage Hepatitis B-related hepatocellular carcinoma.

Liu K, Duan J, Liu H, Yang X, Yang J, Wu M, Chang Y. Liu K, et al. Among authors: liu h. Sci Rep. 2019 May 17;9(1):7700. doi: 10.1038/s41598-019-43791-6. Sci Rep. 2019. PMID: 31097742 Free PMC article.

8

High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.

Lu K, Feng F, Yang Y, Liu K, Duan J, Liu H, Yang J, Wu M, Liu C, Chang Y. Lu K, et al. Among authors: liu k, liu h, liu c. J Gastroenterol. 2020 Jan;55(1):51-66. doi: 10.1007/s00535-019-01627-0. Epub 2019 Sep 27. J Gastroenterol. 2020. PMID: 31562534

9

Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma.

Fan M, Shen J, Liu H, Wen Z, Yang J, Yang P, Liu K, Chang Y, Duan J, Lu K. Fan M, et al. Among authors: liu k, liu h. Oncol Rep. 2017 Aug;38(2):1083-1090. doi: 10.3892/or.2017.5785. Epub 2017 Jul 3. Oncol Rep. 2017. PMID: 28677793

10

Retracted: MicroRNA-34a inhibit hepatocellular carcinoma progression by repressing hexokinase-1.

Zhou Y, Liu K, Liu Y, Tan L. Zhou Y, et al. Among authors: liu k, liu y. J Cell Biochem. 2019 May;120(5):7147-7153. doi: 10.1002/jcb.27988. Epub 2018 Nov 26. J Cell Biochem. 2019. Retraction in: J Cell Biochem. 2022 Feb;123(2):494. doi: 10.1002/jcb.30200 PMID: 30474301 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,973 results

Search Page

Filters